Emestedastat did not significantly slow disease progression, but a prespecified analysis showed a higher rate of zero CDR-SB progression. — From Psychiatric Times articles Read More
Emestedastat for Alzheimer Disease Falls Short Overall, Signals Subgroup Benefit
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT